The two calgranulins S100A8 and S100A9 were found to be dierentially expressed at sites of acute and chronic in¯ammation. Here we have employed the phorbol esterinduced multistage skin carcinogenesis protocol in mice to determine the expression of both genes in in¯amed skin and in skin tumors. We show that expression is coordinately induced by the phorbol ester TPA in epithelial cells as well as in®ltrating leukocytes. By comparing S100A8 and S100A9 mRNA levels in wild type and c-Fos de®cient mice (c-fos
Introduction S100A8 (MRP-8; CP-10; calgranulin A; cystic ®brosis antigen), S100A9 (MRP-14; calgranulin B) and S100A12 (calgranulin C; EN-RAGE) are members of the S100 protein family of highly homologous low molecular weight calcium binding proteins (reviewed by Donato, 2001 ). The calgranulins S100A8 and S100A9 can form a noncovalent heterodimer protein complex called calprotectin, which antagonizes the monomer functions (Newton and Hogg, 1998) .
Calgranulins are characterized by cell type-speci®c expression in cells of epithelial, myeloid and endothelial origin and accumulation at sites of acute and chronic in¯ammation (e.g. rheumatoid arthritis, cystic ®brosis, psoriasis, allergic dermatitis, in¯ammatory bowel diseases) (reviewed by Donato, 2001) . Recently a functional interaction of the calgranulin family member S100A12 with the receptor for advanced glycation end products (RAGE) was discovered . RAGE was found to be involved in in¯ammation , in tumor growth and metastasis (Taguchi et al., 2000) , in wound healing (Goova et al., 2001) , and the pathology of certain diseases such as diabetes and Alzheimer's disease (reviewed by Schmidt et al., 2000) .
The calgranulins S100A8 and S100A9 are currently attracting much interest because of their wide range of possible intracellular as well as extracellular functions (reviewed by Donato, 2001 ). For example, both proteins have been suggested to aect alteration of the cytoskeleton and cell shape, signal transduction, exclusive carrying of arachidonic acids (Kerkho et al., 1999) , and modulation of intracellular calcium (Schafer and Heizmann, 1996) . Moreover, S100A8 and S100A9 have been described to be involved in in¯ammatory conditions (Odink et al., 1987; Brandtzaeg et al., 1987) . Approximately 45% of the cytoplasmic protein fraction of neutrophils is comprised of S100A8 and S100A9 underlining their importance in in¯ammation (Edgeworth et al., 1991) . The release of these small proteins via a TPA (12-Otetradecanoyl-13-phorbolacetate)-stimulated tubulindependent pathway (Rammes et al., 1997) into the extracellular space supports the importance of their extracellular functions which includes potent chemotactic activity, triggering of local in¯ammation, regulation of adhesivity, transendothelial migration of leukocytes and striking antimicrobial properties (Kerkho et al., 1998; Passey et al., 1999a; Steinbakk et al., 1990 ). S100A8-de®cient mouse embryos exhibiting an embryonic lethal phenotype have revealed non-redundant functions of S100A8 protein during fetal implantation (Passey et al., 1999b) , and coordinate expression and secretion of S100A8 and S100A9 proteins have been observed during wound healing and in hyperthickened epithelium (Thorey et al., 2001) . However, neither regulatory mechanisms of gene expression, nor the speci®c functions of the calgranulins S100A8 and S100A9 in in¯ammation-associated processes have yet been identi®ed conclusively.
A frequently used model of acute in¯ammation is TPA-induced edema formation in the skin as the initial part of the chemically induced multistage skin carcinogenesis protocol (reviewed by Marks and FuÈ rstenberger, 1990; Bowden et al., 1994; . Application of TPA to the skin causes swelling associated with increased vascular permeability and rapid in¯ux of neutrophil granulocytes and mononuclear cells into the skin. Cotreatment with glucocorticoids, which are in widespread medical use to inhibit in¯ammatory processes, interferes with both edema formation and the development of papilloma and carcinoma (Belman and Troll, 1972) .
Recently, we have applied PCR-based suppression subtraction hybridization to establish a cDNA library of TPA-inducible genes in mouse skin (Breitenbach et al., 2001) . Two of these clones turned out to encode the calgranulins S100A8 and S100A9. Here we have determined cell type-speci®c expression of both genes in the initial TPA-induced in¯ammatory response and during various stages of skin carcinogenesis. Wild type and c-Fos de®cient mice (c-fos 7/7 ) were used to establish the critical role of c-Fos in calgranulins S100A8 and S100A9 expression and repression by anti-in¯ammatory glucocorticoids.
Results

TPA coordinately induces calgranulins S100A8 and S100A9 expression in skin
In an eort to identify genes in murine skin, which are transiently induced by tumor promoters, we isolated the two calgranulins S100A8 and S100A9 (Breitenbach et al., 2001) . Induction kinetics revealed elevated mRNA levels of S100A8 as well as S100A9 at 4 h after TPA treatment, whereas in the skin of control treated animals only very low basal level expression of both genes could be detected. Maximal levels of induction (over 100-fold) were reached at 6 h, which returned to almost basal levels after 12 h ( Figure 1a and data not shown). Similar to the induction of S100A8 and S100A9 in vivo in skin, in the previously described immortalized mouse keratinocyte cell line PMK-R3 (Rennecke et al., 1999) expression can be eciently induced by TPA (Figure 1b ). These data show that expression of both genes is coordinately induced by TPA and follow similar kinetics as compared to previously described TPA-responsive genes, such as MMP3 and MMP13 (Tuckermann et al., 1999) .
Figure 1 PKC-speci®c induction of calgranulins S100A8 and S100A9 by TPA. (a) Induction of calgranulins S100A8 and S100A9 by TPA in murine skin. TPA (10 nmol) in 100 ml acetone was applied onto the backskin of C57BL/6 mice. After 0, 1, 4, 6 h mice were sacri®ced and RNA from skin was prepared. The level of calgranulins S100A8 and S100A9 transcripts was visualized by Northern analysis. Rehybridization with a cDNA fragment of 18S RNA was performed serving as loading control. One representative experiment out of three independent experiments using tissue pooled from three mice is shown. (b) PKC-speci®c inhibitors suppress TPA-mediated induction of S100A8 and S100A9. PMK-R3 keratinocytes (Rennecke et al., 1999) were treated with acetone (7), 10 nmol TPA (TPA), 100 nmol PKC-inhibitors Goedecke 6983 or 100 nmol Goedecke 6976 dissolved in acetone. Fifteen min before TPA addition. Expression of SPRR2A was chosen for comparison. Cells were harvested for RNA preparation 6 h thereafter and analysed as described in (a) Oncogene Expression of calgranulins S100A8/S100A9 C Gebhardt et al PKC-specific inhibitors suppress TPA-induced upregulation of S100A8 and S100A9 Distinct isoforms of the protein kinase C (PKC) family represent the major`receptor' of the phorbol ester TPA to initiate signaling pathways to the nucleus. To identify the PKC isozymes that might be involved in the upregulation of calgranulins S100A8 and S100A9 by TPA we measured induction of both genes in PMK-R3 cells in the absence or presence of the PKC inhibitors Goedecke 6983 and 6976. These drugs are potent and rather speci®c inhibitors of PKC isozymes, which allow discriminating between isozyme subgroups (Rennecke et al., 2000) . Both, Goedecke 6983 known to reduce preferentially kinase activities of PKCa, PKCd, PKCe and PKCZ as well as Goedecke 6976, which preferentially inhibits PKCa and PKCm, are able to block basal and TPA-induced expression of both calgranulins ( Figure 1b ). This inhibition pattern would be expected for a signaling pathway mediated by the aisozyme of PKC. In contrast, overall expression of the dierentiation-related small proline rich protein SPRR2A (Fischer et al., 1996) was aected by both drugs about twofold, and 1.5-fold induction by TPA was blocked by Goedecke 6983, ruling out the possibility that the block of S100A8 and S100A9 induction can be explained as part of a general inhibition of gene expression by the inhibitors Goedecke 6983 and 6976.
Dexamethasone treatment represses TPA-mediated upregulation of S100A8 and S100A9 expression Glucocorticoids act as anti-in¯ammatory and antitumor promoting agents in skin (Belman and Troll, 1972) and repress the TPA-induced expression of AP-1 target genes such as MMP3 and MMP13 (Tuckermann et al., 1999) . To investigate if glucocorticoids also aect the expression of the calgranulins S100A8 and S100A9 TPA treatment of murine skin was performed in the presence of the synthetic glucocorticoid dexamethasone. As shown in Figure 2 Northern blot analysis revealed that TPA-induced expression of the calgranulins S100A8 and S100A9 is coordinately and strongly repressed by simultaneous glucocorticoid treatment in wild type skin.
c-Fos-dependent regulation of S100A8 and S100A9 expression
The ability of glucocorticoids to interfere with expression of cellular genes is best explained by negative cross-talk between the glucocorticoid receptor (GR) and other transcription factors, such as AP-1 and NFkB (reviewed by Karin, 1998; Herrlich, 2001) , opening the possibility that expression of calgranulins S100A8 and S100A9 might be regulated by NFkB, AP-1 and/or other GR-sensitive transcription factors. To address this question by functional means in vivo we compared expression of S100A8 and S100A9 in wild type mice and in mice de®cient for a critical subunit of AP-1, c-Fos (Wang et al., 1992) . Surprisingly, in comparison to the faint expression of S100A8 and S100A9 in acetone-treated control skin of wild type mice the expression levels of the calgranulins S100A8 and S100A9 in skin of c-fos 7/7 mice were constitutively and coordinately enhanced in the acetone-treated backskin ( Figure 2 ) as well as in untreated backskin (data not shown). Similar to the ®ndings in wild type skin (Figures 1 and 2 ), TPA treatment in c-Fos de®cient mice led to a massive induction of S100A8 and S100A9 (Figure 2 ). These TPA-induced levels show a more than three times higher ratio compared to TPA-treated wild type littermates. Importantly, dexamethasone repressed TPA-induced S100A8 and S100A9 expression only in wild type mice but not in the skin of c-fos 7/7 mice ( Figure 2 ). These data identify calgranulins S100A8 and S100A9 as the ®rst examples of negatively regulated c-Fos target genes whose repression by glucocorticoids depends on c-Fos.
Cell-specific expression of S100A8 and S100A9 in c-Fos-deficient murine skin
To identify the cell types of murine skin expressing the calgranulins S100A8 and S100A9 we performed in situ hybridization analysis of backskin biopsies from untreated and TPA treated wild type and c-fos
mice. Treatment with the tumor promoter TPA produced a local in¯ammation characterized by weak epidermal hyperplasia, dermal and subdermal edema and subcutaneous invasion of in¯ammatory cells. 6 h post-stimulation with TPA strong signals for S100A8 and S100A9 transcripts were detected in the epidermis ( Figure 3 and data not shown). Moreover, S100A8 and S100A9 expression was shown by most of the in¯ammatory in®ltrate (Figure 3b for S100A9; for S100A8 data not shown), such as small mononuclear cells, neutrophils and macrophages invading into the subcutis. On sections of acetone treated control skin of wild type animals expression of both calgranulins was not or only faintly detectable ( Figure 3a and data not shown). In agreement with the Northern blot analysis ( Figure 2 ) strong and coordinate in vivo repression of TPA induced gene expression by dexamethasone treatment was observed in wild type murine backskin. Distinct repression of S100A8 and S100A9 expression was seen in epidermal cells ( Figure 3c and data not shown). The eect was accompanied by the disappearance of S100A8 and S100A9 positive in¯ammatory cells in the subcutis. The small numbers of resting myeloid cells did not show any S100A8 and S100A9 expression.
To quantify these dierences in S100A8 and S100A9 expression in cells of the epidermal and dermal compartments skin from untreated and TPA and/or Dex-treated mice was prepared and the dermis was separated from the epidermis. RNA was prepared and the eciency of separation was con®rmed by RT ± PCR analysis using marker genes of epidermal and dermal cells (keratin-14 and vimentin, respectively; Figure 4b ). Quantitative RT ± PCR analysis of S100A8 Expression of calgranulins S100A8/S100A9
C Gebhardt et al (data not shown) and S100A9 ( Figure 4a , left panel) transcripts revealed that expression of both genes in the epidermis was highly induced by TPA and completely blocked in the presence of dexamethasone, while dexamethasone alone had only a minor eect. Under these conditions, low amounts of S100A8 and S100A9 transcripts in the dermis could only be obtained in TPA-treated mice, suggesting that S100A8 and S100A9 positive in®ltrating in¯ammatory cells represent only a minor fraction of cells of the dermis. In agreement with the block of in®ltration of these cells (Figure 3 ), this induction in S100A8 and S100A9 transcripts is lost upon co-treatment of mouse skin with TPA and dexamethasone.
To answer the question whether dexamethasonedependent repression of S100A8 and S100A9 upregulation in keratinocytes is predominantly due to the repression of the in¯ammatory response or whether it is a direct eect on keratinocytes TPA-induced expression of both genes in the keratinocyte cell line PMK-R3 (Figure 1 ) was analysed in the presence of dexamethasone (Figure 4c ). Quantitative RT ± PCR analysis revealed that induction of both genes is completely abolished by dexamethasone con®rming that repression of TPA-dependent S100A8 and S100A9 upregulation in keratinocytes is a cell-autonomous function and does not rely on the repression of in®ltration of in¯ammatory cells.
In agreement with the data on RNA from total skin (Figure 2 ) in situ hybridization analysis of skin biopsies from c-Fos de®cient mice revealed high basal expression and TPA-induced superinduction of both calgranulins S100A8 (data not shown) and S100A9 (Figure 3g, h ). Enhanced basal expression in untreated skin did not coincide with any in¯ammatory processes, since subdermal edema or subcutaneous in®ltration of in¯ammatory cells as seen in TPA treated skin ( Figure  3b , h) was absent. TPA-induced expression of S100A8 and S100A9 was also shown to be restricted to epidermal as well as in®ltrated in¯ammatory cells in the subcutis (Figure 3h and data not shown). Importantly, in response to dexamethasone treatment, S100A8 and S100A9 expression remained high in the c-fos 7/7 epidermis whereas positive in¯ammatory cells disappeared (Figure 3i and data not shown). This was underlined by quantitative RT ± PCR analysis of S100A8 (data not shown) and S100A9 (Figure 4a ) were treated with 100 ml acetone (co), 10 nmol TPA (TPA), or 10 nmol TPA together with 50 mg dexamethasone (T+D). Animals were sacri®ced after 6 h and RNA was isolated from the backskin. Hybridization was also performed with RNA prepared from squamous cell carcinoma (SCC) obtained from NMRI mice, which were treated according to the multistage skin carcinogenesis protocol (see Materials and methods). S100A8 and S100A9 expression was determined as described in Figure 1 Oncogene Expression of calgranulins S100A8/S100A9 C Gebhardt et al sone-dependent repression of TPA-induced upregulation of both genes in cells of the epidermis. In contrast, repression is observed in cells of the dermis (Figure 4a , right panel, and data not shown), most likely due to the block of in®ltration of in¯ammatory cells.
Calgranulins S100A8 and S100A9 are overexpressed in skin carcinogenesis
Following the multistage skin carcinogenesis protocol (FuÈ rstenberger and Kopp-Schneider, 1995) chronic treatment with TPA results in the formation of epithelial tumors, such as papillomas and, at later stages, aggressively growing squamous cell carcinomas. To monitor the expression pattern of the calgranulins S100A8 and S100A9 throughout carcinogenesis we ®rst determined expression in chronically TPA-treated hyperplastic skin. Here, S100A8 and S100A9 were highly expressed by dierentiating keratinocytes of the hyperplastic epidermis (Figure 5a, d) , which stained positive for involucrin protein (Figure 5g ). Proliferating basal cells, which were identi®ed by PCNA staining (Figure 5j ) did not express detectable levels of either gene. Strong expression of the calgranulins S100A8 and S100A9 restricted to suprabasal keratinocytes of the spinous and granular like layers was also detected in benign papillomas maintaining their colocalization S-UTP labeled antisense (a ± c; g ± i) and sense (d ± f; j ± l) riboprobes of S100A9 were hybridized to transverse sections of the skin from female wild type mice (a ± f) and c-fos 7/7 mice (g ± l) sacri®ced 6 h after the following topical treatments: acetone (control), 10 nmol TPA (TPA), or 10 nmol TPA with 50 mg dexamethasone (TPA+Dex). A representative series of sections out of four dierent experiments is shown. The dark ®eld pictures show an overview of the skin containing epidermis, dermis and subdermal fat tissue. The bright ®eld inlets exhibit a higher magni®cation of an area of the epidermis. Scale bar: 20 mm (bright ®eld) 200 mm (dark ®eld). Very similar expression patterns were found for S100A8 (data not shown)
Expression of calgranulins S100A8/S100A9 C Gebhardt et al Figure 4 c-Fos-dependent repression of TPA-induced S100A8 and S100A9 expression by glucocorticoids in keratinocytes. (a, b) Wild type and c-fos 7/7 mice were treated as described in Figure 3 , skin was prepared and the epidermis (Ep) was separated from the dermis (De). Total RNA obtained from epidermis and dermis was analysed for S100A9 transcripts by quantitative RT ± PCR using b-actin for normalization (a). The levels reached by TPA induced expression were taken as 100%. Bars represent the average of duplicate measurements in two dierent experiments. To con®rm ecient separation of the epidermis from the dermis mRNA levels of two marker genes, keratin 14 and vimentin, were determined (b). (c) PMK-R3 keratinocytes were treated with acetone (co), TPA (T, 100 ng/ml), dexamethasone (Dex, 10 77 M) and TPA in combination with dexamethasone (T+D) for 6 h. Relative mRNA levels of S100A8 and S100A9 were determined by quantitative RT ± PCR using b-actin for normalization. The levels reached by TPA induced expression were taken as 100%. Bars represent the average of triplicate measurements with involucrin and being absent in the proliferating cells (Figure 5b , e, h, k).
At late stages of skin carcinogenesis, where aggressively growing squamous cell carcinomas appear the calgranulins S100A8 and S100A9 were highly expressed (Figure 2) by PCNA negative cells of the epidermal islands formed by keratinocytes (Figure 5c, f, l) . Coexpression of both calgranulins and involucrin could also be observed in carcinomas. In those malignant tumors S100A8 and S100A9 expression was also be seen in myeloid and endothelial cells. In®ltrating in¯ammatory cells invading the malignant carcinomas expressed the calgranulins in high amounts whereas the few myeloid cells in benign papillomas did neither express S100A8 nor S100A9. Accordingly, endothelial cells of blood vessels, which appeared in high numbers in carcinomas, expressed both calgranulins at signi®-cant levels whereas endothelial cells in hyperplastic skin or papillomas did not (data not shown).
These data show that transient upregulation of both calgranulins S100A8 and S100A9 by single treatment with the tumor promoter TPA became constitutive upon chronic treatment of the skin with TPA, resulting in overexpression throughout skin carcinogenesis.
Discussion
The abundant appearance of the calgranulins in acute in¯ammation (Odink et al., 1987 , Zwadlo et al., 1988 Figure 5 S100A8 and S100A9 are coordinately overexpressed during multistage skin carcinogenesis.
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S-UTP labeled antisense riboprobes of S100A8 (a, b, c) and S100A9 (d, e, f) were hybridized to transverse sections of biopsies taken from three stages of murine skin carcinogenesis: chronically TPA-treated hyperplastic skin, benign papillomas, squamous cell carcinomas (SCC). Immunohistochemical analysis of involucrin (g, h, i) and PCNA (j, k, l) expression was done using anti-mouse antibodies on parallel sections. Staining was performed using Fuchsin red. PCNA analysis was counterstained with haematoxylin. Staining with secondary IgG antibodies alone showed no signals (data not shown). Sections are representative for three independent experiments. Scale bar: 200 mm Expression of calgranulins S100A8/S100A9 C Gebhardt et al and other in¯ammatory disorders e.g. psoriasis, rheumatoid arthritis, in¯ammatory bowel diseases and cystic ®brosis (Odink et al., 1987 , Brandtzaeg et al., 1987 , Lugering et al., 1995 has long been noted. Similar to other members of the S100 protein family, S100A8 and S100A9, which are abundantly expressed by neutrophils, monocytes and activated macrophages, may represent functional ligands of the central cell surface receptor RAGE , acting as a center of a new proin¯ammatory axis mediating release of proin¯ammatory cytokines such as TNFa and IFNg .
In the present study we have employed the phorbol ester (TPA)-dependent chemically induced multistage skin carcinogenesis model to analyse expression of calgranulins S100A8 and S100A9 in in¯amed skin and skin tumors. We found that in addition to in®ltrating in¯ammatory cells dierentiating keratinocytes in the epidermis exhibit massive and coordinate expression of S100A8 and S100A9 upon TPA application. Induction of both calgranulins in dierentiating keratinocytes in vivo and in TPA-treated immortalized keratinocytes in vitro aligns with a most recent study showing high expression of S100A8/A9 in terminal dierentiating keratinocytes during wound healing and in hyperthickened epithelium of activinoverexpressing mice even in the absence of in¯amma-tion (Thorey et al., 2001) .
Previously a PKC-dependent activation and release of the calcium-binding proteins S100A8 and S100A9 has been proposed (Rammes et al., 1997) . Here we show that PKC-speci®c inhibitors can block TPAmediated induction of both genes in a keratinocyte cell line. The type of speci®c interference suggests that the a isoform of PKC, a known upstream element of MAPK-signaling pathway (Trautwein et al., 1993) , is involved. PKCa may play an important role in cutaneous in¯ammation as overexpression of PKCa in murine skin leads to local in¯ammation similar to TPA-induced in¯ammation, an increased expression of pro-in¯ammatory mediators e.g. COX-2, MIP-2 and TNFa and an abundant release of arachidonic acid and other eicosanoids (Wang and Smart, 1999; Wang et al., 2001) . On the other hand, TPA-induced expression of genes important in epidermal terminal dierentiation and/or skin carcinogenesis, such as involucrin, loricrin, ®laggrin and members of the SPRR family seem to be PKCamediated (Rutberg et al., 1996) .
What are the transcription factors regulating S100A8 and S100A9 expression in a PKCa-dependent manner? A well-known downstream target of the PKC-MAP kinase-signaling pathway in many tissues including skin is transcription factor AP-1 (for review: Pearson et al., 2001; Chang and Karin, 2001; Angel et al., 2001) . In fact, putative AP-1 binding sites have been found in the murine and human promoter sequences of both genes (Nacken et al., 1996 (Nacken et al., , 2001 ) being part of a potent enhancer element mediating epithelial cell-type speci®c gene expression (Melkonyan et al., 1998; Klempt et al., 1999) . Moreover, transcriptional induction is coordinately repressed by glucocorticoids, which is best explained by negative interference between the activated glucocorticoid receptor and transcription factors involved in the in¯ammatory response, such as AP-1, NFkB and NF-IL-6 (Karin, 1998; Nissen and Yamamoto, 2000; Herrlich, 2001) . While NFkB sites seem not to be present, putative binding sites for NF-IL6 conserved in the murine as well as the human 5'-promoter regions of S100A8 and S100A9 have been de®ned mediating transcriptional activation by IFNg and transrepression by the activated retinoic acid receptor (DiSepio et al., 1997) .
Despite these dierent lines of evidence for a positive function of AP-1 in transcriptional regulation of S100A8 and S100A9, enhanced basal level expression and TPA-dependent superinduction of both genes in c-Fos-de®cient mice clearly shows, that at least one AP-1 subunit, c-Fos, is involved in down-regulation of expression of both genes. In fact, S100A8 and S100A9, in addition to the c-fos gene itself (SchoÈ nthal et al., 1989) , are the ®rst examples of AP-1 target genes, whose downmodulation by cFos has been con®rmed in vivo using genetically de®ned mouse mutants. The mechanism by which cFos downmodulates S100A8 and S100A9 expression is presently unknown. Possibly, by heterodimerization with another AP-1 subunit, speci®c c-Fos-containing dimers may exhibit repression through binding to an AP-1 binding site in the promoter regions of S100A8 and S100A9 genes. Alternatively, repression might be mediated through association with NF-IL6 to alter the DNA binding speci®city of NF-IL6 and reduce its binding to NF-IL6 sites (Hsu et al., 1994) . Regardless of the exact mechanism, the transrepression function of c-Fos is also in line with the pattern of expression in vivo: calgranulins S100A8 and S100A9 expression in hyperplastic epidermis could be detected in all suprabasal keratinocytes while cFos is exclusively expressed in the stratum basale and just prior to corni®cation (Fisher et al., 1991) . Under pathological circumstances such as psoriasis, which are characterized by high levels of S100A8 and S100A9 (Wilkinson et al., 1988) , c-Fos is downregulated (Basset-Seguin et al., 1991) .
Analysing S100A8 and S100A9 expression in wild type and c-fos 7/7 mice we have detected a novel function of c-Fos in downregulation of TPA-induced S100A8 and S100A9 induction in the presence of glucocorticoids. In wild type mice co-treatment with the synthetic glucocorticoid dexamethasone blocked both TPA-induced in®ltration of small mononuclear cells, neutrophils and macrophages into the subcutis and expression of S100A8 and S100A9 in keratinocytes. While repression of in®ltration might be indirect and independent of c-Fos, down-modulation of S100A8 and S100A9 expression occurred in wild type but not in c-fos
mice. The molecular mechanism of interference between c-Fos and the activated glucocorticoid receptor (GR) is still unknown. Either, GR and c-Fos interdepend in the Oncogene Expression of calgranulins S100A8/S100A9 C Gebhardt et al regulation of expression of proteins, which negatively control S100A8 and S100A9 promoter activity. Alternatively, GR is able to suppress c-Fos-containing AP-1 dimeric complexes but not dimers of dierent composition (e.g. containing Fra proteins; Miner and Yamamoto, 1992) , which may functionally replace c-Fos in c-fos 7/7 mice. Although more work will be required to understand the molecular details of c-Fos-dependent GR/AP-1 cross-talk these data and future studies on dexamethasone-mediated transrepression of S100A8 and S100A9 expression may expand our knowledge concerning therapeutic action of glucocorticoids. On the other hand, the presence of S100A8 and S100A9-expressing keratinocytes in TPA and dexamethasone treated c-fos 7/7 mice in the absence of in®ltrating leukocytes provides an additional line of in vivo support for previous suggestions that high expression of S100A8/A9 in keratinocytes may occur even in the absence of in¯ammation (Thorey et al., 2001) .
Massive induction of S100A8 and S100A9 in keratinocytes was not restricted to the in¯ammation-linked early response of TPA treatment of the skin, but rather remained at very high levels throughout skin carcinogenesis in papillomas and squamous cell carcinomas. These ®ndings may point to a novel function of the calgranulins in carcinogenesis, possibly through interaction with speci®c receptors, such as RAGE. Interestingly, abundant basal expression of RAGE in skin tumors has been described (Taguchi et al., 2000) and blockade of RAGE was found to suppress tumor growth and metastasis (Taguchi et al., 2000) . The RAGE ligand calgranulin S100A12 does not seem to be expressed at stages of skin carcinogenesis whereas S100A8/A9 are.
Based on the coordinated regulation and cell type speci®c gene expression in murine skin heterodimers of the calgranulins S100A8 and S100A9 are likely to be the predominant complexes formed during the carcinogenic process. c-Fos de®cient mice show remarkable abnormalities in skin carcinogenesis characterized by lack of malignant progression (Saez et al., 1995) . Despite constitutive and coordinate epidermal expression of the calgranulins S100A8 and S100A9 in untreated c-fos 7/7 mice there are neither signs for alterations in the architecture of the epidermis, nor spontaneous in¯ammation in these animals (Saez et al., 1995; our own unpublished results) . Apparently, overexpression of both calgranulins has no pro-in¯ammatory eects indicating a lack of functionally active chemo-attracting extracellular S100A8 monomers.
Our investigations have provided ®rst evidence for a function of S100A8 and S100A9 in carcinogenesis and may form the basis for strategies to treat this process by manipulating the molar ratio between calgranulin family members or by interference of ligand-receptor interaction between S100A8 and S100A9 with their surface receptor(s), such as RAGE. These studies have to be accompanied by future functional assays to unequivocally con®rm the function of c-Fos-dependent regulation of both calgranulins in skin physiology and pathology.
Materials and methods
Animals
Female C57BL/6J mice aged 7 ± 9 weeks, female NMRI mice (RCC, FuÈ llinsdorf, Switzerland) as well as c-fos 7/7 mice and their wild type littermates (Wang et al., 1992) were housed in speci®c pathogen free (SPF) and in light, temperature (218C) and humidity (50 ± 60% relative humidity) controlled conditions. Food and water were available ad libitum. The procedures for performing animal experiments were in accordance with the principles and guidelines of the ATBW (ocials for animal welfare) and were approved by the RegierungspraÈ sidium Karlsruhe, Germany.
Treatment of mouse skin
C67BL/6 wild type and c-fos 7/7 mice were shaved on the dorsal skin and treated 3 days later topically with 100 ml acetone as control, 10 nmol TPA (12-O-tetradecanoyl-13-phorbolacetate) or 50 mg dexamethasone, each dissolved in 100 ml acetone, or 10 nmol TPA in combination with 50 mg dexamethasone in 100 ml acetone as described previously (Tuckermann et al., 1999) . The animals were sacri®ced at the indicated time points after topical application. Hyperplastic skin was obtained from female NMRI mice. Dorsal skin of 7-week-old animals was shaved and treated twice a week for a period of 7 weeks with single doses of 10 nmol TPA dissolved in acetone. Four days after the ®nal TPA application the animals were sacri®ced and the skin was taken. Skin tumors derived from female NMRI mice used in this study were generated according to the two-stage carcinogenesis protocol using 100 nM 7,12-dimethylbenz[a]anthracene as initiator and TPA (10 nmol / 100 ml per application) as promoter as described previously (FuÈ rstenberger and Kopp-Schneider, 1995) . For RNA extraction tissues and tumors were immediately frozen in liquid nitrogen after isolation. To obtain epidermal and dermal RNA of murine skin separation of the epidermis from the dermis was achieved following the previously described protocol by Winter et al. (1983) . For in situ hybridization and immunohistochemistry tissues were immersed ®xed in 4% paraformaldehyde / PBS and embedded in paran and subsequently cut in 6 mm sections as described previously (Gack et al., 1995) .
Cells
The keratinocyte cell line PMK-R3 was generated by transfection of primary murine keratinocytes with a SV40 T-antigen-expressing vector. Despite expression of keratinocyte-speci®c markers these cells do not signi®cantly respond to increased Ca 2+ concentrations (Rennecke et al., 1999) . Cells were cultivated in minimal essential medium (MEM) with Hank's salt mixture supplemented with a four-fold concentration of amino acids and vitamins, 2 mM glutamine, 2.4 g NaHCO 3 /L, 100 IU penicillin and 100 mg streptomycin/ ml at 348C in a humidi®ed atmosphere of 5% CO 2 and 95% air. Ten per cent fetal bovine serum was added. The PMK-R3 cells were treated for 6 h with acetone (0.5% ®nal concentration), TPA (100 mg/ml), dexamethasone (10
and/or 10 mM of PKC inhibitors Goedecke 6983 or 6976 (obtained from Calbiochem, Schwalbach, Germany).
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Northern blot analysis
Total RNA was isolated from cell lines, from 6 h acetone-, TPA-, as well as TPA plus dexamethasone-treated murine skin and from squamous cell carcinomas, as described previously (Tuckermann et al., 1999) . Fifteen micrograms total RNA were fractionated on 1.4% formaldehyde-agarose gels and subjected to Northern blot analysis using an [a-32 P]dCTP S100A8 (nucleotides 1-221 of the published 343 bp S100A8 sequence; Lagasse and Weissman, 1992) or S100A9 (nucleotides 15-488 of the published 488 bp S100A9 sequence; Lagasse and Weissman, 1992) cDNA insert. Both fragments were isolated by restriction enzyme digest of the appropriate pCR2.1 plasmid (Breitenbach et al., 2001) . Each sample was hybridized in at least three experiments. The probe for 18S rRNA used as loading control was obtained by RT ± PCR using RNA from mouse skin. Quanti®cation was performed by using Phosphoimager (Molecular Dynamics, Krefeld, Germany).
Reverse transcription and PCR
cDNA synthesis of total RNA was performed as described previously (Reichardt et al., 2001) . Quantitative PCR was performed using a Lightcycler System according to the manufacturers instructions (Roche Diagnostics, Mannheim, Germany) using the following primers: 5'-GGAAATCAC-CATGCCCTCTA-3' and 5'-GCTGTCTTTGTGAGATGC-CA-3' for the ampli®cation of a 189 bp fragment of S100A8, 5'-TCATCGACACCTTCCATCAA-3' and 5'-GATCAACT-TTGCCATCAGCA-3' for the ampli®cation of a 227 bp fragment of S100A9, 5'-CAAGGATGCTGAGGAATGGT-3' and 5'-CCGGAGCTCAGAAATCTCAC-3' for the ampli®-cation of a 113 bp fragment of keratin 14, 5'-CAGATGCGT-GAGATGGAAGA-3' and 5'-TCCAGCAGCTTCCTGTA-GGT-3' for the ampli®cation of a 200 bp fragment of vimentin, and 5'-TGGACAGTGAGGCCAGGATG-3' and 5'-TCGTGCGTGACATCAAAGAG-3' for the ampli®cation of a 429 bp fragment of b-actin (annealing at 598C).
In situ hybridization
In situ hybridization was performed on six mm paran sections as previously described (Gack et al., 1995) . All samples were ®xed in 4% paraformaldehyde, treated with proteinase K (20 mg/ml) and subsequently washed in 0.1 M triethanolamine buer containing 0.25% acetic anhydride. The sections were covered with 20 ± 100 ml of hybridization buer containing 1.5610 5 c.p.m./ml of 35 S-labeled antisense or sense RNA probe, and incubated at 538C for 18 h in a humidi®ed chamber. After hybridization, the slides were washed under stringent conditions (50% formamide, 658C), including treatment with RNase A (20 mg/ml) to remove unhybridized probe. After 4 ± 10 days of exposure, the NTB2 photographic emulsion (Kodak, MuÈ nchen, Germany) was developed, and the slides were stained with hematoxylin and eosin. Each sample was hybridized in at least three experiments. S100A8 and S100A9 cRNA probes were derived by in vitro transcription from the appropriate EcoRI linearized recombinant pCR2.1 plasmid described above. As a control for nonspeci®c hybridization, sections were hybridized with 35 S-labeled sense RNA from the pCR2.1 plasmid linearised with BamHI.
Immunohistochemistry
Paran sections (thickness 6 mm) from skin biopsies were treated as described previously (Schnarr et al., 2000) followed by incubation with primary antibody (rabbit polyclonal antiInvolucrin, 1 : 1500 dilution in 0.1% BSA/TBS; BabCO, Richmond, USA; goat anti-rabbit IgG anti-PCNA, 1 : 50 dilution in 0.1% BSA/TBS; Dianova, Hamburg, Germany) for 16 h at 48C in a humid chamber. After thorough rinsing with 50 mM Tris-buer (pH 7.4) sections were incubated with avidin and biotin-block for 15 min each (Avidin-BiotinBlocking Kit, Vector SP-2001; Linaris, MuÈ nchen, Germany) and then incubated with the secondary antibody (biotinylated goat anti-rabbit IgG, 1 : 200 dilution, from ABC-Vectastain Kit, Vector AK-5002; Linaris; biotinylated anti-mouse IgG, 1 : 200 dilution, from, ABC-Vectastain Kit, Vector AK-5002; Linaris) for 30 min. Incubation was followed by two cycles of incubation with an 1 : 10 diluted mouse alkaline phosphataseanti-alkaline-phosphatase complex (APAAP; Linaris). After washing with distilled water for 5 min, sections were incubated with naphthol AS-BI phosphate (Sigma, MuÈ nchen, Germany) as substrate and stained with fuchsin (Sigma) as chromogen. Sections incubated with PCNA were additionally counterstained with haematoxylin. Blocking of endogenous alkaline phosphatase was achieved by adding 1.73 mM levamisol (Sigma). Samples incubated without primary antibody served as negative controls.
